Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells

Journal of Surgical Research

Volumn 91, Issue 1, 2000, Pages 9-14

  Heisler, Tracy ^a   Towfigh, Shirin ^a   Simon, Natalie ^a   McFadden, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Hormone receptors; Peptide YY; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL; HORMONE RECEPTOR; PEPTIDE YY;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034214310     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5881     Document Type: Article

References (19)

1. Surveillance, epidemiology, and end results program, American Cancer Society, Inc, 1997.
2. Surveillance research, American Cancer Society, Inc, 1998.
3. Kalser M. H., Ellenberg S. S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 120:1985;899.
4. Tatemoto K., Nakano I., Makk G., Angwin P., Mann M., Schilling J., Go V. L. Isolation and primary structure of human peptide YY. Biochem. Biophys. Res. Commun. 157:1988;713.
5. Böttcher G., Sjöberg J., Ekman R., Håkanson R., Sundler F. Peptide YY in the mammalian pancreas: Immunocytochemical localization and immunochemical characterization. Regul. Pept. 43:1993;115.
6. Brodish R. J., Kuvshinoff B. W., Fink A. S., McFadden D. W. Effects of intraluminal peptide YY on pancreatic function. Int. J. Pancreatol. 12:1992;153.
7. Brodish R. J., Kuvshinoff B. W., Fink A. S., McFadden D. W. Peptide YY inhibits pancreatic secretion via cholinergic pathways. J. Surg. Res. 55:1993;103.
8. Liu C. D., Balasubramaniam A., Saxton R. E., Paiva M., McFadden D. W. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J. Surg. Res. 58:1995;707.
9. Eberlein G. A., Eysselein V. E., Schaeffer M., Layer P., Grandt D., Goebell H., Niebel W., Davis M., Lee T. D., Shively J. E. A new molecular form of PYY: Structural characterization of human PYY(3-36) and PYY(1-36). Peptides. 10:1989;797.
10. Liu C. D., Slice L. W., Balasubramaniam A., Walsh J. H., Newton T. R., Saxton R. E., McFadden D. W. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. Surgery. 118:1995;235.
11. Steinmetz K. A., Potter J. D. Vegetables, fruit, and cancer prevention: A review. J. Am. Diet. Assoc. 96:1996;1027.
12. Israel K., Sanders B. G., Kline K. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutr. Cancer. 24:1995;161.
13. Prasad K. N. Mechanisms of action of vitamin E on mammalian tumor cells in culture. Prog. Clin. Biol. Res. 259:1988;363.
14. Nesaretnam K., Stephen R., Dils R., Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids. 33:1998;461.
15. Yu W., Israel K., Liao Q. Y., Aldaz C. M., Sanders B. G., Kline K. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: Role for Mr 43, 000 Fas in VES-triggered apoptosis. Cancer Res. 59:1999;953.
16. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47:1987;936.
17. McHale A. P., McHale L. Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro. Cancer Lett. 41:1988;315.
18. Bendich A., Machlin L. J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48:1988;612.
19. Prasad K. N., Edwards-Prasad J. Vitamin E and cancer prevention: Recent advances and future potentials [see comments]. J. Am. Coll. Nutr. 11:1992;487.